Effects of the WRITE Symptoms Interventions on Symptoms and Quality of Life Among Patients With Recurrent Ovarian Cancers: An NRG Oncology/GOG Study (GOG-0259)

Author:

Donovan Heidi S.12ORCID,Sereika Susan M.1ORCID,Wenzel Lari B.3ORCID,Edwards Robert P.2,Knapp Judith E.1,Hughes Susan H.4,Roberge Mary C.1,Thomas Teresa H.1ORCID,Klein Sara Jo1,Spring Michael B.5,Nolte Susan6,Landrum Lisa M.7,Casey A. Catherine8,Mutch David G.9ORCID,DeBernardo Robert L.10,Muller Carolyn Y.11,Sullivan Stephanie A.12,Ward Sandra E.4

Affiliation:

1. University of Pittsburgh School of Nursing, Pittsburgh, PA

2. Magee Womens Hospital of UPMC Hillman Cancer Center, Pittsburgh, PA

3. Medicine and Public Health, University of California, Irvine, CA

4. University of Wisconsin, Madison, WI

5. University of Pittsburgh School of Computing and Information, Pittsburgh, PA

6. Abington Memorial Hospital, Gynecologic Oncology Institute, Abington, PA

7. Stephenson Cancer Center Gynecologic Cancers Clinic, University of Oklahoma Health Sciences Center, Oklahoma City, OK

8. Minnesota Oncology, Edina, MN

9. Washington University School of Medicine, Siteman Cancer Center, St Louis, MO

10. Obstetrics and Gynecology, Cleveland Clinic, Cleveland, OH

11. Gynecologic Oncology, UNM School of Medicine, University of New Mexico Albuquerque, NM

12. Gynecology Oncology, VCU Medical Center North Hospital, Richmond, VA

Abstract

PURPOSE GOG-259 was a 3-arm randomized controlled trial of two web-based symptom management interventions for patients with recurrent ovarian cancer. Primary aims were to compare the efficacy of the nurse-guided (Nurse-WRITE) and self-directed (SD-WRITE) interventions to Enhanced Usual Care (EUC) in improving symptoms (burden and controllability) and quality of life (QOL). METHODS Patients with recurrent or persistent ovarian, fallopian, or primary peritoneal cancer with 3+ symptoms were eligible for the study. Participants completed baseline (BL) surveys (symptom burden and controllability and QOL) before random assignment. WRITE interventions lasted 8 weeks to develop symptom management plans for three target symptoms. All women received EUC: monthly online symptom assessment with provider reports; online resources; and every 2-week e-mails. Outcomes were evaluated at 8 and 12 weeks after BL. Repeated-measures modeling with linear contrasts evaluated group by time effects on symptom burden, controllability, and QOL, controlling for key covariates. RESULTS Participants (N = 497) reported mean age of 59.3 ± 9.2 years. At BL, 84% were receiving chemotherapy and reported a mean of 14.2 ± 4.9 concurrent symptoms, most commonly fatigue, constipation, and peripheral neuropathy. Symptom burden and QOL improved significantly over time ( P < .001) for all three groups. A group by time interaction ( P < .001) for symptom controllability was noted whereby both WRITE intervention groups had similar improvements from BL to 8 and 12 weeks, whereas EUC did not improve over time. CONCLUSION Both WRITE Intervention groups showed significantly greater improvements in symptom controllability from BL to 8 and BL to 12 weeks compared with EUC. There were no significant differences between Nurse-WRITE and SD-WRITE. SD-WRITE has potential as a scalable intervention for a future implementation study.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3